Zealand Pharma A/S (NASDAQ:ZEAL)

Delayed Data
As of Jun 04
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Zealand Pharma A/S have a median target of 42.33, with a high estimate of 58.00 and a low estimate of 33.11. The median estimate represents a +8.64% increase from the last price of 38.96.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Zealand Pharma A/S. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 65.54%
Growthannually -4.63%


Growthquarterly 1,524.40%
Growthannually 652.93%
Key to the earnings and sales forecast charts.